	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M PRESS	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Total Revenue	-	684	4,949	4,773	4,136	4,178	4,388
Cost of Operating Revenue	-	475	3,550	3,528	2,907	2,845	2,888
Gross Profit	-	209	1,399	1,245	1,228	1,332	1,500
Gross Margin	-	30.5	28.3	26.1	29.7	31.9	34.2
Total Operating Expenses	0	586	4,215	4,329	3,842	3,810	3,997
Operating Profit	0	98	734	444	294	368	392
Operating Margin	-	14.4	14.8	9.3	7.1	8.8	8.9
Financing Income/(Expense) - Net	-	-10	-46	-38	-54	-59	-49
Profit before Taxes	0	77	709	437	268	344	370
Income Taxes	-	23	232	129	85	92	92
Profit after Tax	0	54	477	307	183	251	278
PAT Margin	-	7.9	9.6	6.4	4.4	6.0	6.3
EPS - Basic - ex Extraordinary Items	-0.01	3.41	29.98	19.34	11.56	15.89	17.59
EPS - Diluted - ex Extraordinary Items	-0.01	3.41	29.97	19.34	11.55	15.84	17.51
EBIT	0	98	734	444	294	368	392
EBITDA	0	120	857	566	430	526	567
EBITDA Margin	-	17.6	17.3	11.9	10.4	12.6	12.9

Balance Sheet

Abridged

Understanding Balance Sheet

Jubilant Ingrevia Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	PRESS	AR	AR	AR	AR	AR	PRESS
Total Current Assets	0	1,424	1,765	1,818	1,780	1,853	2,046
Long-Term Investments	-	48	3	3	10	14	39
Property Plant & Equipment - Net	-	1,857	1,958	2,357	2,850	3,083	3,302
Total Non-Current Assets	-	1,955	2,033	2,441	2,952	3,179	3,437
Total Assets	0	3,379	3,797	4,259	4,732	5,032	5,484
Total Current Liabilities	0	894	1,053	1,180	1,286	1,401	1,592
Long Term Debt	-	464	106	157	430	368	330
Total Non-Current Liabilities	-	561	311	413	708	704	766
Total Liabilities	0	1,456	1,364	1,593	1,994	2,105	2,358
Total Shareholders' Equity	0	1,923	2,433	2,666	2,737	2,927	3,126
Total Equity	0	1,923	2,433	2,666	2,737	2,927	3,126
Total Liabilities & Equity	0	3,379	3,797	4,259	4,732	5,032	5,484

Cash Flow

Abridged

Understanding Cash Flow Statement

Jubilant Ingrevia Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M PRESS	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	-0.17	101.90	722.25	464.72	356.95	414.97	447.98
Working Capital - Increase/(Decrease)	0.17	0.95	-301.22	-45.15	5.87	22.79	14.06
Net CF from Operating Activities	-	102.85	421.03	419.57	362.81	437.76	462.04
Capital Expenditures - Net	-	27.50	227.55	478.17	566.15	352.19	289.52
Net CF from Investing Activities	-	-43.66	-73.19	-473.00	-569.50	-396.05	-276.82
Dividends Paid - Cash - Total	-	-	45.16	79.31	78.62	79.77	79.25
Stock - Issuance/(Retirement) - Net	0.05	-	-18.26	-	-42.89	4.38	-30.05
Debt - LT & ST - Issuance/(Retirement) - Total	-	-62.94	-321.30	164.92	333.53	20.21	16.95
Net Cash Flow from Financing Activities	0.05	-62.94	-384.71	85.60	212.02	-55.18	-92.35
Free Cash Flow to Equity	-	12.42	-127.81	106.31	130.19	105.78	189.47
Free Operating CF net dividend	-	75.31	145.73	-141.13	-284.18	-7.81	83.43
Free Operating CF	-	75.31	190.88	-61.82	-205.56	71.97	162.68

Business Segment Analysis

FY End:

Mar 25

Jubilant Ingrevia Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Nutrition & Health Solutions (45.8%)₹ 183.30 CrSpeciality Chemicals (40.1%)₹ 160.38 CrChemical Intermediates (13.5%)₹ 54.03 CrUnallocated corporate assets (0.5%)₹ 2.19 Cr

Revenue / Sales

Speciality Chemicals (46.5%)₹ 2,060.98 CrChemical Intermediates (36.6%)₹ 1,621.66 CrNutrition & Health Solutions (16.9%)₹ 747.97 Cr

Assets

Speciality Chemicals (55.8%)₹ 2,809.79 CrChemical Intermediates (26.9%)₹ 1,351.11 CrNutrition & Health Solutions (14.4%)₹ 723.06 CrUnallocated corporate assets (2.9%)₹ 147.80 Cr

Regional Segment Analysis

FY End:

Mar 25

Jubilant Ingrevia Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

India (54.1%)₹ 2,259.81 CrAmericas and Europe (35.7%)₹ 1,492.88 CrRest of the World (7.3%)₹ 306.68 CrChina (2.8%)₹ 118.24 Cr

Historical Segment Analysis

Track how Jubilant Ingrevia Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Business

Regional

Business

	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31

Nutrition & Health Solutions	3	11	18	79	183
Speciality Chemicals	18	147	320	468	160
Chemical Intermediates	22	81	188	99	54
Unallocated corporate assets	0	1	0	1	2

Frequently Asked Questions

What is the revenue of Jubilant Ingrevia Ltd.?

The latest trailing twelve month revenue of Jubilant Ingrevia Ltd. is ₹ 4,388.07 Cr, reflecting a 1-year growth of 5.04% and a 3-year CAGR of -2.76%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Jubilant Ingrevia Ltd.?

The latest trailing twelve month net profit (PAT) of Jubilant Ingrevia Ltd. is ₹ 277.91 Cr, with a 3-year earnings CAGR of -3.25%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Jubilant Ingrevia Ltd.?

The trailing twelve month EBITDA of Jubilant Ingrevia Ltd. is approximately ₹ 391.56 Cr (based on an operating margin of 8.92%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Jubilant Ingrevia Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Jubilant Ingrevia Ltd. is 17.51. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Jubilant Ingrevia Ltd.?

The debt-to-equity ratio of Jubilant Ingrevia Ltd. stands at 0.25. The interest coverage ratio is 7.97x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Jubilant Ingrevia Ltd.?

The estimated book value per share of Jubilant Ingrevia Ltd. is 197.79 (derived from a P/B ratio of 3.73 and market price of ₹ 738.00), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Jubilant Ingrevia Ltd.?

The trailing twelve month operating cash flow of Jubilant Ingrevia Ltd. is ₹ 462.04 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Jubilant Ingrevia Ltd. report consolidated or standalone financials?

Jubilant Ingrevia Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.